Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China flag China · Delayed Price · Currency is CNY
30.85
+0.19 (0.62%)
At close: Sep 16, 2026

Bright Eye Hospital Group Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,9102,7672,6602,7051,7151,703
Other Revenue
30.1830.1818.5912.7911.097.4
2,9402,7972,6782,7181,7261,710
Revenue Growth
8.20%4.44%-1.46%57.50%0.91%25.54%
Cost of Revenue
1,7171,6591,5611,424927.51903.36
Gross Profit
1,2231,1391,1171,294798.13806.66
Selling, General & Admin
1,004985.181,012913.35694.23627.16
Research & Development
10.3910.828.0211.036.64-
Other Operating Expenses
3.385.338.125.893.192.67
Operating Expenses
1,0201,0031,028933.65705.65629.83
Operating Income
203.44136.0188.92360.3792.47176.83
Interest Expense
-19.33-19.33-16.97-74.67-57.56-48.44
Interest & Investment Income
4.754.28.5495.3529.5413.75
Currency Exchange Gain (Loss)
-0.01-0.01-0.05-0.41-0.01-
Other Non Operating Income (Expenses)
-71.65-73.71-77.67-31.69-13.59-5.87
EBT Excluding Unusual Items
117.2147.162.78348.9650.84136.27
Impairment of Goodwill
-7.69-7.69-4.54--1.64-8.12
Gain (Loss) on Sale of Investments
-9.59-10.17-3.510.1--
Gain (Loss) on Sale of Assets
-0.390-0.930.060.560.93
Asset Writedown
-1.27-1.1-1.46-0.47-0.47-0.5
Other Unusual Items
-15.69-15.69-18.3613.589.9410.33
Pretax Income
82.5712.52-26.02362.2359.23138.9
Income Tax Expense
61.7566.2366.8184.2338.6645.01
Earnings From Continuing Operations
20.82-53.72-92.83278.0120.5793.89
Minority Interest in Earnings
-8.3-7.2-9.03-10.09--
Net Income
12.52-60.92-101.86267.9120.5793.89
Net Income to Common
12.52-60.92-101.86267.9120.5793.89
Net Income Growth
---1202.56%-78.09%-13.81%
Shares Outstanding (Basic)
150149150150129112
Shares Outstanding (Diluted)
150149150150129112
Shares Change
0.97%-0.80%0.08%16.43%15.01%-0.39%
EPS (Basic)
0.08-0.41-0.681.790.160.84
EPS (Diluted)
0.08-0.41-0.681.790.160.84
EPS Growth
---1018.75%-80.95%-13.40%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
374.93318.45-160.43-12.41-8.68104.62
Free Cash Flow Per Share
2.502.14-1.07-0.08-0.070.94
Dividend Per Share
---0.4000.100-
Dividend Growth
---300.00%--
Gross Margin
41.60%40.71%41.70%47.61%46.25%47.17%
Operating Margin
6.92%4.86%3.32%13.26%5.36%10.34%
Profit Margin
0.43%-2.18%-3.80%9.86%1.19%5.49%
Free Cash Flow Margin
12.75%11.38%-5.99%-0.46%-0.50%6.12%
EBITDA
350.72278.86213.26451.57162.32232.68
EBITDA Margin
11.93%9.97%7.96%16.61%9.41%13.61%
D&A For EBITDA
147.28142.85124.3491.269.8455.85
EBIT
203.44136.0188.92360.3792.47176.83
EBIT Margin
6.92%4.86%3.32%13.26%5.36%10.34%
Effective Tax Rate
74.79%529.21%-23.25%65.27%32.41%
Revenue as Reported
2,7972,7972,6782,7181,7261,710
Advertising Expenses
-230.39220.74240.06197.96178.68